Italian performance in cancer research

Andrea Micheh, Francesca Di Salvo, Claudio Lombardo, Roberta Ciampichin, Donatella Ugolini, Paolo Bailit, Marco A. Pierotti

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Aims and background. Italian performance in cancer research from 2000 to 2007 was assessed and compared to that of the other 19 wealthiest countries in the world which carry out the bulk of cancer research. Methods. Performance was evaluated quantitatively as the number of publications in 125 journals indexed as 'oncological' by Journal Citation Reports and qualitatively as the total impact factor (TIF). Number of publications and TIF were adjusted for the population and gross domestic product (GDP) of each country. The Scopus database was used as publication source. Results. Italy ranked 5th, with the US ranking lb', over the entire study period for number of cancer publications, which increased over that period. Italy ranked 4thi in 2006- 2007 for GDP-adjusted and 5" for population-adjusted publication number, loosing ground in the GDP-adjusted ranking and gaining ground in the population-adjusted ranking over the study period. When the quality of research publications was considered, in 2006-2007 Italy was in 5t place for crude TIF (US 1st), in 4,h place for GDP-adjusted TIP (Sweden 1st), and in 6th place for population-adjusted TIF (Sweden 1st). Over the study period, Italy was stable for crude and population-adjusted TIF but declined somewhat for GDP- adjusted TIP. Conclusions. Italy's performance in cancer research over the eight years to 2008 was better than expected considering its GDP and population. Nevertheless, the slight decline evidenced by the present study should induce scientists and policy makers to find ways to reverse the situation.

Original languageEnglish
Pages (from-to)133-141
Number of pages9
JournalTumori
Volume95
Issue number2
Publication statusPublished - Mar 2009

Fingerprint

Gross Domestic Product
Publications
Italy
Research
Neoplasms
Population
Sweden
Population Dynamics
Administrative Personnel
Databases

Keywords

  • Cancer research
  • Impact factor
  • Italy

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Micheh, A., Di Salvo, F., Lombardo, C., Ciampichin, R., Ugolini, D., Bailit, P., & Pierotti, M. A. (2009). Italian performance in cancer research. Tumori, 95(2), 133-141.

Italian performance in cancer research. / Micheh, Andrea; Di Salvo, Francesca; Lombardo, Claudio; Ciampichin, Roberta; Ugolini, Donatella; Bailit, Paolo; Pierotti, Marco A.

In: Tumori, Vol. 95, No. 2, 03.2009, p. 133-141.

Research output: Contribution to journalArticle

Micheh, A, Di Salvo, F, Lombardo, C, Ciampichin, R, Ugolini, D, Bailit, P & Pierotti, MA 2009, 'Italian performance in cancer research', Tumori, vol. 95, no. 2, pp. 133-141.
Micheh A, Di Salvo F, Lombardo C, Ciampichin R, Ugolini D, Bailit P et al. Italian performance in cancer research. Tumori. 2009 Mar;95(2):133-141.
Micheh, Andrea ; Di Salvo, Francesca ; Lombardo, Claudio ; Ciampichin, Roberta ; Ugolini, Donatella ; Bailit, Paolo ; Pierotti, Marco A. / Italian performance in cancer research. In: Tumori. 2009 ; Vol. 95, No. 2. pp. 133-141.
@article{5e705453a4b0434d8510774a4367f408,
title = "Italian performance in cancer research",
abstract = "Aims and background. Italian performance in cancer research from 2000 to 2007 was assessed and compared to that of the other 19 wealthiest countries in the world which carry out the bulk of cancer research. Methods. Performance was evaluated quantitatively as the number of publications in 125 journals indexed as 'oncological' by Journal Citation Reports and qualitatively as the total impact factor (TIF). Number of publications and TIF were adjusted for the population and gross domestic product (GDP) of each country. The Scopus database was used as publication source. Results. Italy ranked 5th, with the US ranking lb', over the entire study period for number of cancer publications, which increased over that period. Italy ranked 4thi in 2006- 2007 for GDP-adjusted and 5{"} for population-adjusted publication number, loosing ground in the GDP-adjusted ranking and gaining ground in the population-adjusted ranking over the study period. When the quality of research publications was considered, in 2006-2007 Italy was in 5t place for crude TIF (US 1st), in 4,h place for GDP-adjusted TIP (Sweden 1st), and in 6th place for population-adjusted TIF (Sweden 1st). Over the study period, Italy was stable for crude and population-adjusted TIF but declined somewhat for GDP- adjusted TIP. Conclusions. Italy's performance in cancer research over the eight years to 2008 was better than expected considering its GDP and population. Nevertheless, the slight decline evidenced by the present study should induce scientists and policy makers to find ways to reverse the situation.",
keywords = "Cancer research, Impact factor, Italy",
author = "Andrea Micheh and {Di Salvo}, Francesca and Claudio Lombardo and Roberta Ciampichin and Donatella Ugolini and Paolo Bailit and Pierotti, {Marco A.}",
year = "2009",
month = "3",
language = "English",
volume = "95",
pages = "133--141",
journal = "Tumori",
issn = "0300-8916",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Italian performance in cancer research

AU - Micheh, Andrea

AU - Di Salvo, Francesca

AU - Lombardo, Claudio

AU - Ciampichin, Roberta

AU - Ugolini, Donatella

AU - Bailit, Paolo

AU - Pierotti, Marco A.

PY - 2009/3

Y1 - 2009/3

N2 - Aims and background. Italian performance in cancer research from 2000 to 2007 was assessed and compared to that of the other 19 wealthiest countries in the world which carry out the bulk of cancer research. Methods. Performance was evaluated quantitatively as the number of publications in 125 journals indexed as 'oncological' by Journal Citation Reports and qualitatively as the total impact factor (TIF). Number of publications and TIF were adjusted for the population and gross domestic product (GDP) of each country. The Scopus database was used as publication source. Results. Italy ranked 5th, with the US ranking lb', over the entire study period for number of cancer publications, which increased over that period. Italy ranked 4thi in 2006- 2007 for GDP-adjusted and 5" for population-adjusted publication number, loosing ground in the GDP-adjusted ranking and gaining ground in the population-adjusted ranking over the study period. When the quality of research publications was considered, in 2006-2007 Italy was in 5t place for crude TIF (US 1st), in 4,h place for GDP-adjusted TIP (Sweden 1st), and in 6th place for population-adjusted TIF (Sweden 1st). Over the study period, Italy was stable for crude and population-adjusted TIF but declined somewhat for GDP- adjusted TIP. Conclusions. Italy's performance in cancer research over the eight years to 2008 was better than expected considering its GDP and population. Nevertheless, the slight decline evidenced by the present study should induce scientists and policy makers to find ways to reverse the situation.

AB - Aims and background. Italian performance in cancer research from 2000 to 2007 was assessed and compared to that of the other 19 wealthiest countries in the world which carry out the bulk of cancer research. Methods. Performance was evaluated quantitatively as the number of publications in 125 journals indexed as 'oncological' by Journal Citation Reports and qualitatively as the total impact factor (TIF). Number of publications and TIF were adjusted for the population and gross domestic product (GDP) of each country. The Scopus database was used as publication source. Results. Italy ranked 5th, with the US ranking lb', over the entire study period for number of cancer publications, which increased over that period. Italy ranked 4thi in 2006- 2007 for GDP-adjusted and 5" for population-adjusted publication number, loosing ground in the GDP-adjusted ranking and gaining ground in the population-adjusted ranking over the study period. When the quality of research publications was considered, in 2006-2007 Italy was in 5t place for crude TIF (US 1st), in 4,h place for GDP-adjusted TIP (Sweden 1st), and in 6th place for population-adjusted TIF (Sweden 1st). Over the study period, Italy was stable for crude and population-adjusted TIF but declined somewhat for GDP- adjusted TIP. Conclusions. Italy's performance in cancer research over the eight years to 2008 was better than expected considering its GDP and population. Nevertheless, the slight decline evidenced by the present study should induce scientists and policy makers to find ways to reverse the situation.

KW - Cancer research

KW - Impact factor

KW - Italy

UR - http://www.scopus.com/inward/record.url?scp=67649088875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67649088875&partnerID=8YFLogxK

M3 - Article

C2 - 19579856

AN - SCOPUS:67649088875

VL - 95

SP - 133

EP - 141

JO - Tumori

JF - Tumori

SN - 0300-8916

IS - 2

ER -